ABOUT PHARMA EXCIPIENTS

“The present scenario has uncovered some structural weaknesses while in the EU’s medicines offer chain and a high dependence on non-EU countries for active pharmaceutical ingredients,” Kyriakides said. She advisable that provide chain challenges be addressed within an EU pharmaceutical approach predicted to become launched by the tip in the 1